On the role of NOS1 ex1f‐VNTR in ADHD—allelic, subgroup, and meta‐analysis
暂无分享,去创建一个
B. Franke | K. Lesch | B. Cormand | C. Sánchez-Mora | J. Ramos-Quiroga | M. Ribasés | A. Alttoa | S. Johansson | S. Kittel-Schneider | J. Haavik | A. Reif | L. Kent | F. Freudenberg | H. Weber | S. Herterich | L. Weissflog | O. B. Fasmer | A. Halmøy | A. Post | E. T. Landaas | J. Heupel
[1] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[2] Kourosh Masoumeh Arami,et al. Neuronal Nitric Oxide Synthase , 2017 .
[3] K. Lesch,et al. Sex- and Subtype-Related Differences of Personality Disorders (Axis II) and Personality Traits in Persistent ADHD , 2016, Journal of attention disorders.
[4] A. Alttoa,et al. Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders , 2015, Genes, brain, and behavior.
[5] M. Quirynen,et al. Oral health: Risk definition in halitosis , 2014, BDJ.
[6] A. Bao,et al. Nitric oxide synthase and nitric oxide alterations in chronically stressed rats: A model for nitric oxide in major depressive disorder , 2014, Psychoneuroendocrinology.
[7] Astrid Dempfle,et al. Internalizing and externalizing behavior in adult ADHD , 2014, ADHD Attention Deficit and Hyperactivity Disorders.
[8] D. Swaab,et al. Decreased NOS1 expression in the anterior cingulate cortex in depression. , 2013, Cerebral cortex.
[9] F. Guimarães,et al. Antidepressant- and anticompulsive-like effects of purinergic receptor blockade: Involvement of nitric oxide , 2013, European Neuropsychopharmacology.
[10] Jianxin Shi,et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.
[11] M. Daly,et al. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis , 2013, The Lancet.
[12] P. Lichtenstein,et al. Developmental twin study of attention problems: high heritabilities throughout development. , 2013, JAMA psychiatry.
[13] Tim Hahn,et al. NOS1 ex1f‐VNTR polymorphism affects prefrontal oxygenation during response inhibition tasks , 2012, Human brain mapping.
[14] K. Lesch,et al. Association of a functional variant of the nitric oxide synthase 1 gene with personality, anxiety, and depressiveness , 2012, Development and Psychopathology.
[15] Y. Yazır,et al. Inhibition of Neuronal Nitric Oxide Synthase and Soluble Guanylate Cyclase Prevents Depression‐Like Behaviour in Rats Exposed to Chronic Unpredictable Mild Stress , 2012, Basic & clinical pharmacology & toxicology.
[16] P. Lichtenstein,et al. Genetic and environmental influences on adult attention deficit hyperactivity disorder symptoms: a large Swedish population-based study of twins , 2012, Psychological Medicine.
[17] J. Tanus-Santos,et al. Inducible nitric oxide synthase haplotype associated with migraine and aura , 2012, Molecular and Cellular Biochemistry.
[18] B. Franke,et al. The genetics of attention deficit/hyperactivity disorder in adults, a review , 2011, Molecular Psychiatry.
[19] L. Kiemeney,et al. DIRAS2 is Associated with Adult ADHD, Related Traits, and Co-Morbid Disorders , 2011, Neuropsychopharmacology.
[20] F. López-Muñoz,et al. Corticotropin-Releasing Factor and Hypothalamic–Pituitary–Adrenal Axis Regulation of Behavioral Stress Response and Depression , 2011 .
[21] Thomas Dresler,et al. NOS1 ex1f-VNTR polymorphism influences prefrontal brain oxygenation during a working memory task , 2011, NeuroImage.
[22] K. Oedegaard,et al. Adult attention deficit hyperactivity disorder is associated with migraine headaches , 2011, European Archives of Psychiatry and Clinical Neuroscience.
[23] M. Maes,et al. Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder. , 2011, Journal of affective disorders.
[24] Marika Paaver,et al. A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity , 2011, Psychopharmacology.
[25] A. Lundervold,et al. Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder , 2010, Expert review of neurotherapeutics.
[26] K. Lesch,et al. The effect of a functional NOS1 promoter polymorphism on impulsivity is moderated by platelet MAO activity , 2010, Psychopharmacology.
[27] Stefan Johansson,et al. Multicenter Analysis of the SLC6A3/DAT1 VNTR Haplotype in Persistent ADHD Suggests Differential Involvement of the Gene in Childhood and Persistent ADHD , 2010, Neuropsychopharmacology.
[28] J. Haavik,et al. Bipolar symptoms in adult attention-deficit/hyperactivity disorder: a cross-sectional study of 510 clinically diagnosed patients and 417 population-based controls. , 2010, The Journal of clinical psychiatry.
[29] Michael Gill,et al. Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects. , 2009, Archives of general psychiatry.
[30] J. Kurth,et al. The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease , 2009, Journal of neuroscience research.
[31] Benjamin M. Neale,et al. Genome-wide association studies in ADHD , 2009, Human Genetics.
[32] C. Gillberg,et al. Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5‐microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[33] S. A. Stevenson,et al. Altered gene expression in mice selected for high maternal aggression , 2007, Genes, brain, and behavior.
[34] K. Lesch,et al. Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center , 2007, European Archives of Psychiatry and Clinical Neuroscience.
[35] R. Nelson,et al. Pleiotropic contributions of nitric oxide to aggressive behavior , 2006, Neuroscience & Biobehavioral Reviews.
[36] S. Faraone,et al. Candidate gene studies of attention-deficit/hyperactivity disorder. , 2006, The Journal of clinical psychiatry.
[37] D Saur,et al. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function , 2006, Molecular Psychiatry.
[38] Joseph Biederman,et al. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies , 2005, Psychological Medicine.
[39] A. Moorman,et al. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data , 2003, Neuroscience Letters.
[40] R. Spanagel,et al. The Neuronal Nitric Oxide Synthase Gene Is Critically Involved in Neurobehavioral Effects of Alcohol , 2002, The Journal of Neuroscience.
[41] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[42] R. Nelson,et al. Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[43] S. Gammie,et al. Maternal Aggression Is Reduced in Neuronal Nitric Oxide Synthase-Deficient Mice , 1999, The Journal of Neuroscience.
[44] S. Snyder,et al. Nitric oxide and carbon monoxide: parallel roles as neural messengers 1 Published on the World Wide Web on 21 October 1997. 1 , 1998, Brain Research Reviews.
[45] J. Ioannidis,et al. Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.
[46] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[47] J. Fleiss,et al. Statistical methods for rates and proportions , 1973 .
[48] W. Haenszel,et al. Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.
[49] S. Joca,et al. Nitric Oxide Signaling in Depression and Antidepressant Action , 2016 .
[50] L. Kiemeney,et al. DIRAS2 is Associated with Adult ADHD, Related Traits, and Co-Morbid Disorders , 2012, Neuropsychopharmacology.
[51] E. Szigethy,et al. Inflammatory bowel disease. , 2011, Pediatric clinics of North America.
[52] D. Rujescu,et al. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. , 2009, Archives of general psychiatry.
[53] D. Rujescu,et al. Influence of NOS 1 on Verbal Intelligence and Working Memory in Both Patients With Schizophrenia and Healthy Control Subjects , 2009 .
[54] K. Lesch,et al. Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals. , 2007, Journal of neural transmission. Supplementum.